Osteotomy Clinical Trials

Clinical trials related to Osteotomy Procedure

Effect of Implant Macro-Design and Surface Treatment on Insertion Torque and Early Implant Stability Quotient (ISQ): A Pilot Randomized Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This prospective, randomized pilot clinical trial will evaluate the effect of dental implant macro-design and surface treatment on insertion torque values (ITV) and early implant stability quotient (ISQ) trajectories in healed posterior mandibular bone. The study has been approved by the Vilnius University Regional Bioethics Committee (approval no. 2025/11-1722-1165) and will be conducted at a private dental clinic (Dantų implantologijos centras, Vilnius, Lithuania). Fifty implants will be randomly allocated to five groups of ten implants each, comparing two implant macro-designs - Straumann Bone Level Tapered (BLT) and Megagen BlueDiamond (BD) - combined with different surface treatments: (1) BLT with a sandblasted, large-grit, acid-etched (SLA®) surface plus chairside vacuum plasma activation (XActive®); (2) BLT with a manufacturer-hydrophilic SLActive® surface; (3) BD with a nanostructured calcium-incorporated Xpeed® surface plus chairside plasma activation; (4) BD with the standard Xpeed® surface (no plasma activation); and (5) BLT with a standard SLA surface (control, no plasma activation). Randomization will be performed by drawing a sealed envelope indicating group assignment immediately after osteotomy preparation and before implant placement. Eligible participants will be adults aged 18 years or older requiring a single dental implant in a healed mandibular molar site (at least 3 months post-extraction) suitable for a 4.1 × 10 mm implant. Insertion torque will be recorded in Newton centimeters (Ncm) using a prosthetic torque wrench at the time of implant placement. Implant stability will be measured non-invasively by resonance frequency analysis (RFA) using a SmartPeg, with ISQ recorded at four timepoints: at implant placement (baseline) and at 2, 4, and 6 weeks after placement. The primary comparisons will be (1) insertion torque according to implant macro-design (BLT vs. BD) and (2) the trajectory of ISQ change from baseline through 6 weeks according to surface treatment/plasma activation status. Correlation between insertion torque and ISQ will also be assessed. Also marginal bone maintenance (loss) will be documented from periapical radiographs obtained during prosthetic and 1 year follow-up visits. As a pilot study, this trial is designed to assess feasibility, estimate effect sizes, and inform sample-size calculations for a future, adequately powered randomized controlled trial comparing implant macro-design and surface activation strategies for early implant stability.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Age ≥ 18 years

• Requiring a dental implant in a healed mandibular molar site (≥ 3 months post-extraction)

• Site anatomy suitable for placement of a 4.1 × 10 mm implant

• Bleeding on probing \< 20%

• Plaque index \< 25%

Locations
Other Locations
Lithuania
Dantu implantologijos centras
RECRUITING
Vilnius
Contact Information
Primary
Marius Svedas
svedasm@gmail.com
+37069829987
Time Frame
Start Date: 2026-07-13
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 50
Treatments
Experimental: Straumann Bone Level Tapered implants SLA with Plasma X Motion treatment (BLT SLA XActive)
Participants will receive a Straumann Bone Level Tapered (BLT) implant with a conventional sandblasted, large-grit, acid-etched (SLA) surface. Immediately prior to placement, the implant will undergo chairside low-temperature vacuum plasma surface activation using the Plasma X Motion system (XActive®), performed according to the manufacturer's protocol (approximately 50-second activation cycle) immediately before insertion into the prepared osteotomy.
Experimental: Straumann Bone Level Tapeded implants with SLActive surface (BLT SLActive)
Participants will receive a Straumann Bone Level Tapered (BLT) implant with the manufacturer hydrophilic SLActive surface. No chairside plasma activation will be performed; the hydrophilic, hydrocarbon-free surface state is achieved during manufacturing and preserved through storage in isotonic saline under nitrogen until use
Experimental: MegaGen BlueDiamond implants Xpeed surface treated using Plasma X Motion (BD XpeedActive)
Participants will receive a Megagen BlueDiamond (BD) implant with the nanostructured calcium-incorporated Xpeed® surface. Immediately prior to placement, the implant will undergo chairside low-temperature vacuum plasma surface activation using the Plasma X Motion system (XActive®), performed according to the manufacturer's protocol immediately before insertion into the prepared osteotomy.
Experimental: MegaGen BlueDiamond implants Xpeed surface (BD Xpeed)
Participants will receive a Megagen BlueDiamond (BD) implant with the manufacturer nanostructured calcium-incorporated Xpeed® surface, without any chairside plasma activation.
Active_comparator: Straumann Bone Level Tapeded implants with SLActive surface (BLT SLA)
Participants will receive a Straumann Bone Level Tapered (BLT) implant with a conventional sandblasted, large-grit, acid-etched (SLA) surface, without any chairside plasma activation and without a manufacturer-integrated hydrophilic treatment. This arm serves as the reference/control group for surface-treatment comparisons.
Related Therapeutic Areas
Sponsors
Collaborators: MegaGen
Leads: Dantu implantologijos centras

This content was sourced from clinicaltrials.gov